Ironwood Pharmaceuticals, Inc. (IRWD)
3.60
+0.03
(+0.84%)
USD |
NASDAQ |
Mar 03, 13:12
Ironwood Pharmaceuticals Shareholders Equity (Quarterly) : -261.84M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -3.27B |
| Outlook Therapeutics, Inc. | -38.55M |
| Nektar Therapeutics | 85.09M |
| Rigel Pharmaceuticals, Inc. | 117.61M |
| Recursion Pharmaceuticals, Inc. | 1.131B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 396.90M |
| Total Liabilities (Quarterly) | 658.74M |
| Debt to Equity Ratio | -2.283 |
| Current Ratio | 1.132 |
| Net Debt Paydown Yield | 0.62% |